Endocrine disruption of oestrogen action and female reproductive tract cancers

Endocrine-Related Cancer

Volumn 21, Issue 2, 2014, Pages

  Gibson, Douglas A ^a   Saunders, Philippa T K ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Bisphenol A; Diethylstilbestrol; Dioxin; Endocrine disrupting chemical; Endocrine disruptor; Endometrial cancer; Genistein; HOX genes; Obesity; Oestrogen receptor; Phytoestrogen; Reproductive cancer

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4,4' ISOPROPYLIDENEDIPHENOL; ANTIANDROGEN; AROMATIC HYDROCARBON RECEPTOR; BENZOPHENONE DERIVATIVE; CHLORPHENOTANE; COUMESTROL; DIOXIN; ENDOCRINE DISRUPTOR; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GENISTEIN; PHYTOESTROGEN; POLYBROMINATED BIPHENYL; POLYCHLORINATED BIPHENYL; POLYCHLORINATED BIPHENYL DERIVATIVE; PROGESTERONE RECEPTOR;

BINDING AFFINITY; CELL DIFFERENTIATION; CHEMICAL CARCINOGENESIS; ENDOMETRIUM CANCER; ESTROGEN RESPONSIVE ELEMENT; FEMALE; FEMALE GENITAL SYSTEM; GENE EXPRESSION; GENITAL SYSTEM; GYNECOLOGIC CANCER; HORMONAL CARCINOGENESIS; HOX GENE; HUMAN; IN VITRO STUDY; LIFESTYLE; NONHUMAN; PROTEIN EXPRESSION; REPRODUCTIVE HEALTH; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; X RAY CRYSTALLOGRAPHY;

BISPHENOL A; DIETHYLSTILBESTROL; DIOXIN; ENDOCRINE DISRUPTING CHEMICAL; ENDOCRINE DISRUPTOR; ENDOMETRIAL CANCER; GENISTEIN; HOX GENES; OBESITY; OESTROGEN RECEPTOR; PHYTOESTROGEN; REPRODUCTIVE CANCER;

ANIMALS; ENDOCRINE DISRUPTORS; ENVIRONMENTAL POLLUTANTS; ESTROGENS; FEMALE; GENES, HOMEOBOX; GENITAL DISEASES, FEMALE; HUMANS; MENOPAUSE; NEOPLASMS; PUBERTY; RECEPTORS, ESTROGEN;

EID: 84899890828     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0342     Document Type: Review

References (202)

1. Abraham GE 1974 Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 39 340-346. (doi:10.1210/jcem-39-2-340)
2. Aghajanova L & Giudice LC 2011 Effect of bisphenol A on human endometrial stromal fibroblasts in vitro. Reproductive BioMedicine Online 22 249-256. (doi:10.1016/j.rbmo.2010.12.007)
3. Akbas GE, Song J & Taylor HS 2004 A HOXA10 estrogen response element (ERE) is differentially regulated by 17b-estradiol and diethylstilbestrol (DES). Journal of Molecular Biology 340 1013-1023. (doi:10.1016/j.jmb. 2004.05.052)
4. Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A, Lukanova A, Peeters PH, Onland-Moret NC, Lahmann PH, Berrino F et al. 2008 Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocrine-Related Cancer 15 485-497. (doi:10.1677/ERC-07-0064)
5. Alvarado-Cabrero I, Stolnicu S, Kiyokawa T, Yamada K, Nikaido T & Santiago-Payan H 2013 Carcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 127 patients with evaluation of staging and prognostic factors. Annals of Diagnostic Pathology 17 159-164. (doi:10.1016/j.anndiagpath.2012.10.001)
6. Arcaro KF, Yi L, Seegal RF, Vakharia DD, Yang Y, Spink DC, Brosch K & Gierthy JF 1999 2, 2, 6, 6-Tetrachlorobiphenyl is estrogenic in vitro and in vivo. Journal of Cellular Biochemistry 72 94-102. (doi:10.1002/(SICI)1097- 4644(19990101)72:1!94:AID-JCB10O3.0.CO;2-Y)
7. Arem H, Park Y, Pelser C, Ballard-Barbash R, Irwin ML, Hollenbeck A, Gierach GL, Brinton LA, Pfeiffer RM & Matthews CE 2013 Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. Journal of the National Cancer Institute 105 342-349. (doi:10.1093/jnci/djs530)
8. Ashby J & Tinwell H 1998 Uterotrophic activity of bisphenol A in the immature rat. Environmental Health Perspectives 106 719-720. (doi:10.1289/ehp.98106719)
9. Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, Gilbert M, Hamann U & Scott RJ 2009 Estrogen receptor polymorphisms and the risk of endometrial cancer. BJOG: an International Journal of Obstetrics and Gynaecology 116 1053-1061. (doi:10.1111/j.1471-0528.2009. 02185.x)
10. Barnes-Ellerbe S, Knudsen KE & Puga A 2004 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin blocks androgen-dependent cell proliferation of LNCaP cells through modulation of pRB phosphorylation. Molecular Pharmacology 66 502-511. (doi:10.1124/mol.104.000356)
11. Bektic J, Berger AP, Pfeil K, Dobler G, Bartsch G & Klocker H 2004 Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor b. European Urology 45 245-251. (doi:10.1016/j.eururo.2003. 09.001)
12. Beral V, Bull D & Reeves G 2005a Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 365 1543-1551. (doi:10.1016/S0140-6736(05)66455-0)
13. Beral V, Reeves G & Banks E 2005b Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal women. BJOG: an International Journal of Obstetrics and Gynaecology 112 692-695. (doi:10.1111/j.1471-0528.2005.00541.x)
14. Bergman L, Beelen ML, Gallee MP, Hollema H, Benraadt J & van Leeuwen FE 2000 Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. Lancet 356 881-887. (doi:10.1016/S0140-6736(00)02677-5)
15. Bergman A, Heindel JJ, Kasten T, Kidd KA, Jobling S, Neira M, Zoeller RT, Becher G, Bjerregaard P, Bornman R et al. 2013 The impact of endocrine disruption: a consensus statement on the state of the science. Environmental Health Perspectives 121 A104-A106. (doi:10.1289/ehp. 1205448)
16. Bergstrom A, Pisani P, Tenet V, Wolk A & Adami HO 2001 Overweight as an avoidable cause of cancer in Europe. International Journal of Cancer 91 421-430. (doi:10.1002/1097-0215(200002)9999:9999!:AID-IJC1053O3.0.CO;2-T)
17. Bertazzi PA, Pesatori AC, Bernucci I, Landi MT & Consonni D 1999 Dioxin exposure and human leukemias and lymphomas. Lessons from the Seveso accident and studies on industrial workers. Leukemia 13 (Suppl 1) S72-S74. (doi:10.1038/sj.leu.2401290)
18. Biesiada J, Porollo A, Velayutham P, Kouril M & Meller J 2011 Survey of public domain software for docking simulations and virtual screening. Human Genomics 5 497-505. (doi:10.1186/1479-7364-5-5-497)
19. Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W, Shi L, Perkins R & Sheehan DM 2000 The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicological Sciences54 138-153. (doi:10.1093/toxsci/54.1.138)
20. Blanck HM, Marcus M, Tolbert PE, Rubin C, Henderson AK, Hertzberg VS, Zhang RH & Cameron L 2000 Age at menarche and tanner stage in girls exposed in utero and postnatally to polybrominated biphenyl. Epidemiology 11 641-647. (doi:10.1097/00001648-200011000-00005)
21. Block K, Kardana A, Igarashi P & Taylor HS 2000 In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing Müllerian system. FASEB Journal 14 1101-1108.
22. Bombail V, MacPherson S, Critchley HO & Saunders PT 2008 Estrogen receptor related b is expressed in human endometrium throughout the normal menstrual cycle. Human Reproduction 23 2782-2790. (doi:10.1093/humrep/den298)
23. Bombail V, Collins F, Brown P & Saunders PT 2010 Modulation of ERa transcriptional activity by the orphan nuclear receptor ERRb and evidence for differential effects of long-and short-form splice variants. Molecular and Cellular Endocrinology 314 53-61. (doi:10.1016/j.mce. 2009.09.007)
24. Bosch FX & de Sanjose S 2007 The epidemiology of human papillomavirus infection and cervical cancer. Disease Markers 23 213-227. (doi:10.1155/2007/ 914823)
25. Brake T & Lambert PF 2005 Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papilloma-virus-transgenic mouse model. PNAS 102 2490-2495. (doi:10.1073/pnas. 0409883102)
26. Bromer JG, Wu J, Zhou Y & Taylor HS 2009 Hypermethylation of homeobox A10 by in utero diethylstilbestrol exposure: an epigenetic mechanism for altered developmental programming. Endocrinology 150 3376-3382. (doi:10.1210/en.2009-0071)
27. Bromer JG, Zhou Y, Taylor MB, Doherty L & Taylor HS 2010 Bisphenol-A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. FASEB Journal 24 2273-2280. (doi:10.1096/fj.09-140533)
28. Brophy JT, Keith MM, Watterson A, Park R, Gilbertson M, Maticka-Tyndale E, Beck M, Abu-Zahra H, Schneider K, Reinhartz A et al. 2012 Breast cancer risk in relation to occupations with exposure to carcinogens and endocrine disruptors: a Canadian case-control study. Environmental Health 11 87. (doi:10.1186/1476-069X-11-87)
29. Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V & Olea N 1995 Xenoestrogens released from lacquer coatings in food cans. Environmental Health Perspectives 103 608-612. (doi:10.1289/ehp.95103608)
30. Bulun SE, Economos K, Miller D & Simpson ER 1994 CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. Journal of Clinical Endocrinology and Metabolism 79 1831-1834. (doi:10.1210/jc.79.6. 1831)
31. Bulun SE, Chen D, Lu M, Zhao H, Cheng Y, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S et al. 2007 Aromatase excess in cancers of breast, endometrium and ovary. Journal of Steroid Biochemistry and Molecular Biology 106 81-96. (doi:10.1016/j.jsbmb.2007.05.027)
32. Buttke DE, Sircar K & Martin C 2012 Exposures to endocrine-disrupting chemicals and age of menarche in adolescent girls in NHANES (2003-2008). Environmental Health Perspectives 120 1613-1618. (doi:10.1289/ehp.1104748)
33. Calle EE, Rodriguez C, Walker-Thurmond K & Thun MJ 2003 Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New England Journal of Medicine 348 1625-1638. (doi:10.1056/ NEJMoa021423)
34. Canchola AJ, Chang ET, Bernstein L, Largent JA, Reynolds P, Deapen D, Ursin G & Horn-Ross PL 2010 Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort. Cancer Causes & Control 21 1407-1416. (doi:10.1007/s10552-010-9568- 8)
35. Ceccatelli R, Faass O, Schlumpf M & Lichtensteiger W 2006 Gene expression and estrogen sensitivity in rat uterus after developmental exposure to the polybrominated diphenylether PBDE 99 and PCB. Toxicology 220 104-116. (doi:10.1016/j.tox.2005.12.004)
36. Cederquist K, Emanuelsson M, Goransson I, Holinski-Feder E, Muller-Koch Y, Golovleva I & Gronberg H 2004 Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden. International Journal of Cancer 109 370-376. (doi:10.1002/ijc.11718)
37. Charn TH, Liu ET, Chang EC, Lee YK, Katzenellenbogen JA & Katzenellenbogen BS 2010 Genome-wide dynamics of chromatin binding of estrogen receptors a and b: mutual restriction and competitive site selection. Molecular Endocrinology 24 47-59. (doi:10.1210/me.2009-0252)
38. Chung SH, Shin MK, Korach KS & Lambert PF 2013 Requirement for stromal estrogen receptor a in cervical neoplasia. Hormones & Cancer 4 50-59. (doi:10.1007/s12672-012-0125-7)
39. Colborn T, vom Saal FS & Soto AM 1993 Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environmental Health Perspectives 101 378-384. (doi:10.1289/ehp.93101378)
40. Collins F, MacPherson S, Brown P, Bombail V, Williams AR, Anderson RA, Jabbour HN & Saunders PT 2009 Expression of oestrogen receptors, ERa, ERb, and ERb variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERa. BMC Cancer 9 330. (doi:10.1186/1471-2407-9-330)
41. Cooke GM, Price CA & Oko RJ 1998 Effects of in utero and lactational exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) on serum androgens and steroidogenic enzyme activities in the male rat reproductive tract. Journal of Steroid Biochemistry and Molecular Biology 67 347-354. (doi:10.1016/S0960- 0760(98)00127-7)
42. Couse JF & Korach KS 2004 Estrogen receptor-A mediates the detrimental effects of neonatal diethylstilbestrol (DES) exposure in the murine reproductive tract. Toxicology 205 55-63. (doi:10.1016/j.tox. 2004.06.046)
43. Couse JF, Davis VL, Hanson RB, Jefferson WN, McLachlan JA, Bullock BC, Newbold RR & Korach KS 1997 Accelerated onset of uterine tumors in transgenic mice with aberrant expression of the estrogen receptor after neonatal exposure to diethylstilbestrol. Molecular Carcinogenesis 19 236-242. (doi:10.1002/(SICI)1098-2744(199708)19:4!236:AID-MC4O3.0.CO;2-A)
44. Couse JF, Dixon D, Yates M, Moore AB, Ma L, Maas R & Korach KS 2001 Estrogen receptor-A knockout mice exhibit resistance to the developmental effects of neonatal diethylstilbestrol exposure on the female reproductive tract. Developmental Biology 238 224-238. (doi:10.1006/dbio.2001.0413)
45. Crain DA, Janssen SJ, Edwards TM, Heindel J, Ho SM, Hunt P, Iguchi T, Juul A, McLachlan JA, Schwartz J et al. 2008 Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertility and Sterility 90 911-940. (doi:10.1016/j. fertnstert.2008.08.067)
46. Cramer SF & Patel A 1990 The frequency of uterine leiomyomas. American Journal of Clinical Pathology 94 435-438.
47. Critchley HO, Brenner RM, Henderson TA, Williams K, Nayak NR, Slayden OD, Millar MR & Saunders PT 2001 Estrogen receptor b, but not estrogen receptor a, is present in the vascular endothelium of the human and nonhuman primate endometrium. Journal of Clinical Endocrinology and Metabolism 86 1370-1378. (doi:10.1210/jc.86.3.1370)
48. Critchley HO, Henderson TA, Kelly RW, Scobie GS, Evans LR, Groome NP & Saunders PT 2002 Wild-type estrogen receptor (ERb1) and the splice variant (ERbcx/b2) are both expressed within the human endometrium throughout the normal menstrual cycle. Journal of Clinical Endocrinology and Metabolism 87 5265-5273. (doi:10.1210/jc.2002-020502)
49. Cunha GR 1976 Stromal induction and specification of morphogenesis and cytodifferentiation of the epithelia of the Müllerian ducts and urogenital sinus during development of the uterus and vagina in mice. Journal of Experimental Zoology 196 361-370. (doi:10.1002/jez. 1401960310)
50. Daftary GS & Taylor HS 2006 Endocrine regulation of HOX genes. Endocrine Reviews 27 331-355. (doi:10.1210/er.2005-0018)
51. Davis VL, Newbold RR, Couse JF, Rea SL, Gallagher KM, Hamilton KJ, Goulding EH, Jefferson W, Eddy EM, Bullock BC et al. 2012 Expression of a dominant negative estrogen receptor a variant in transgenic mice accelerates uterine cancer induced by the potent estrogen diethyl-stilbestrol. Reproductive Toxicology 34 512-521. (doi:10.1016/j.reprotox. 2012.08.005)
52. De Coster S & van Larebeke N 2012 Endocrine-disrupting chemicals: associated disorders and mechanisms of action. Journal of Environmental and Public Health 2012 713696. (doi:10.1155/2012/713696)
53. Diel P, Smolnikar K, Schulz T, Laudenbach-Leschowski U, Michna H & Vollmer G 2001 Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium. Human Reproduction 16 997-1006. (doi:10.1093/humrep/16.5.997)
54. Doll A, Abal M, Rigau M, Monge M, Gonzalez M, Demajo S, Colas E, Llaurado M, Alazzouzi H, Planaguma J et al. 2008 Novel molecular profiles of endometrial cancer-new light through old windows. Journal of Steroid Biochemistry and Molecular Biology 108 221-229. (doi:10.1016/j.jsbmb.2007.09.020)
55. Dossus L, Lukanova A, Rinaldi S, Allen N, Cust AE, Becker S, Tjonneland A, Hansen L, Overvad K, Chabbert-Buffet N et al. 2013 Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort-A factor analysis. American Journal of Epidemiology 177 787-799. (doi:10.1093/aje/kws309)
56. Dubeau L 2008 The cell of origin of ovarian epithelial tumours. Lancet Oncology 9 1191-1197. (doi:10.1016/S1470-2045(08)70308-5)
57. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P & Mark M 2000 Effect of single and compound knockouts of estrogen receptors a (ERa) and b (ERb) on mouse reproductive phenotypes. Development 127 4277-4291.
58. van Duursen MBM, Sanderson JT, van der Bruggen M, van der Linden J & van den Berg M 2003 Effects of several dioxin-like compounds on estrogen metabolism in the malignant MCF-7 and nontumorigenic MCF-10A human mammary epithelial cell lines. Toxicology and Applied Pharmacology 190 241-250. (doi:10.1016/S0041-008X(03)00166-2)
59. Ehrlich S, Williams PL, Hauser R, Missmer SA, Peretz J, Calafat AM & Flaws JA 2013 Urinary bisphenol A concentrations and cytochrome P450 19 A1 (Cyp19) gene expression in ovarian granulosa cells: an in vivo human study. Reproductive Toxicology 42C 18-23. (doi:10.1016/j.reprotox.2013.06.071)
60. Emons G, Fleckenstein G, Hinney B, Huschmand A & Heyl W 2000 Hormonal interactions in endometrial cancer. Endocrine-Related Cancer 7 227-242. (doi:10.1677/erc.0.0070227)
61. Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS, Xie Q, Dial SL, Moland CL et al. 2001 Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chemical Research in Toxicology 14 280-294. (doi:10.1021/tx000208y)
62. Fang H, Tong W, Branham WS, Moland CL, Dial SL, Hong H, Xie Q, Perkins R, Owens W & Sheehan DM 2003 Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor. Chemical Research in Toxicology 16 1338-1358. (doi:10.1021/tx030011g)
63. Faqi AS & Chahoud I 1998 Antiestrogenic effects of low doses of 2, 3, 7, 8-TCDD in offspring of female rats exposed throughout pregnancy and lactation. Bulletin of Environmental Contamination and Toxicology 61 462-469. (doi:10.1007/s001289900785)
64. Fedirko V, Jenab M, Rinaldi S, Biessy C, Allen NE, Dossus L, Onland-Moret NC, Schutze M, Tjonneland A, Hansen L et al. 2013 Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Annals of Epidemiology 23 93-98. (doi:10.1016/j.annepidem.2012.11.009)
65. Fei X, Chung H & Taylor HS 2005 Methoxychlor disrupts uterine Hoxa10 gene expression. Endocrinology 146 3445-3451. (doi:10.1210/en.2005-0341)
66. Flesken-Nikitin A, Hwang CI, Cheng CY, Michurina TV, Enikolopov G & Nikitin AY 2013 Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche. Nature 495 241-245. (doi:10.1038/nature11979)
67. Fowler PA, Anderson RA, Saunders PT, Kinnell H, Mason JI, Evans DB, Bhattacharya S, Flannigan S, Franks S, Monteiro A et al. 2011 Development of steroid signaling pathways during primordial follicle formation in the human fetal ovary. Journal of Clinical Endocrinology and Metabolism 96 1754-1762. (doi:10.1210/jc.2010-2618)
68. Freyberger A & Ahr H-J 2004 Development and standardization of a simple binding assay for the detection of compounds with affinity for the androgen receptor. Toxicology 195 113-126. (doi:10.1016/j.tox.2003. 09.008)
69. Frigo DE, Burow ME, Mitchell KA, Chiang TC & McLachlan JA 2002 DDT and its metabolites alter gene expression in human uterine cell lines through estrogen receptor-independent mechanisms. Environmental Health Perspectives 110 1239-1245. (doi:10.1289/ehp.021101239)
70. Gaido KW, Leonard LS, Lovell S, Gould JC, Babai D, Portier CJ & McDonnell DP 1997 Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicology and Applied Pharmacology 143 205-212. (doi:10.1006/taap.1996.8069)
71. Gibson DA & Saunders PT 2012 Estrogen dependent signaling in reproductive tissues-A role for estrogen receptors and estrogen related receptors. Molecular and Cellular Endocrinology 348 361-372. (doi:10.1016/j.mce.2011.09.026)
72. Gierthy JF, Spink BC, Figge HL, Pentecost BT & Spink DC 1996 Effects of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin, 12-O-tetradecanoylphorbol-13-acetate and 17b-estradiol on estrogen receptor regulation in MCF-7 human breast cancer cells. Journal of Cellular Biochemistry 60 173-184. (doi:10.1002/(SICI)1097- 4644(19960201)60:2!173:AID-JCB2O3.0. CO;2-U)
73. Giguere V 2002 To ERR in the estrogen pathway. Trends in Endocrinology and Metabolism 13 220-225. (doi:10.1016/S1043-2760(02)00592-1)
74. Goodfellow PJ, Buttin BM, Herzog TJ, Rader JS, Gibb RK, Swisher E, Look K, Walls KC, Fan MY & Mutch DG 2003 Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. PNAS 100 5908-5913. (doi:10.1073/pnas. 1030231100)
75. Gore AC, Walker DM, Zama AM, Armenti AE & Uzumcu M 2011 Early life exposure to endocrine-disrupting chemicals causes lifelong molecular reprogramming of the hypothalamus and premature reproductive aging. Molecular Endocrinology 25 2157-2168. (doi:10.1210/me.2011-1210)
76. Govarts E, Nieuwenhuijsen M, Schoeters G, Ballester F, Bloemen K, de Boer M, Chevrier C, Eggesbo M, Guxens M, Kramer U et al. 2012 Birth weight and prenatal exposure to polychlorinated biphenyls (PCBs) and dichlorodiphenyldichloroethylene (DDE): a meta-analysis within 12 European Birth Cohorts. Environmental Health Perspectives 120 162-170. (doi:10.1289/ehp. 1103767)
77. Greaves E, Collins F, Critchley HO & Saunders PT 2013 ERb-dependent effects on uterine endothelial cells are cell specific and mediated via Sp1. Human Reproduction 28 2490-2501. (doi:10.1093/humrep/det235)
78. Grochowalski A, Chrzaszcz R, Pieklo R & Gregoraszczuk EL 2001 Estrogenic and antiestrogenic effect of in vitro treatment of follicular cells with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Chemosphere 43 823-827. (doi:10.1016/S0045-6535(00)00440-9)
79. Gruber CJ, Tschugguel W, Schneeberger C & Huber JC 2002 Production and actions of estrogens. New England Journal of Medicine 346 340-352. (doi:10.1056/NEJMra000471)
80. Hale GE, Hughes CL & Cline JM 2002 Endometrial cancer: hormonal factors, the perimenopausal "window of risk, " and isoflavones. Journal of Clinical Endocrinology and Metabolism 87 3-15. (doi:10.1210/jc.87.1. 3)
81. Hall JM & McDonnell DP 1999 The estrogen receptor b-isoform (ERb) of the human estrogen receptor modulates ERa transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140 5566-5578. (doi:10.1210/en.140.12.5566)
82. Hall JM, Couse JF & Korach KS 2001 The multifaceted mechanisms of estradiol and estrogen receptor signaling. Journal of Biological Chemistry 276 36869-36872. (doi:10.1074/jbc.R100029200)
83. Hardell L, van Bavel B, Lindstrom G, Bjornfoth H, Orgum P, Carlberg M, Sorensen CS & Graflund M 2004 Adipose tissue concentrations of p, p-DDE and the risk for endometrial cancer. Gynecologic Oncology 95 706-711. (doi:10.1016/j.ygyno.2004.08.022)
84. Harris HA, Katzenellenbogen JA & Katzenellenbogen BS 2002 Characterization of the biological roles of the estrogen receptors, ERa and ERb, in estrogen target tissues in vivo through the use of an ERa-selective ligand. Endocrinology 143 4172-4177. (doi:10.1210/en.2002-220403)
85. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Treuter E, Warner M et al. 2007 Estrogen receptors: how do they signal and what are their targets. Physiological Reviews 87 905-931. (doi:10.1152/physrev.00026.2006)
86. Henderson TA, Saunders PT, Moffett-King A, Groome NP & Critchley HO 2003 Steroid receptor expression in uterine natural killer cells. Journal of Clinical Endocrinology and Metabolism 88 440-449. (doi:10.1210/jc.2002-021174)
87. Herbst AL, Ulfelder H & Poskanzer DC 1971 Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. New England Journal of Medicine 284 878-881. (doi:10.1056/ NEJM197104222841604)
88. Hickey TE, Robinson JL, Carroll JS & Tilley WD 2012 Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? Molecular Endocrinology 26 1252-1267. (doi:10.1210/me.2012-1107)
89. Hiroi H, Tsutsumi O, Takeuchi T, Momoeda M, Ikezuki Y, Okamura A, Yokota H & Taketani Y 2004 Differences in serum bisphenol a concentrations in premenopausal normal women and women with endometrial hyperplasia. Endocrine Journal 51 595-600. (doi:10.1507/endocrj.51.595)
90. Hoover RN, Hyer M, Pfeiffer RM, Adam E, Bond B, Cheville AL, Colton T, Hartge P, Hatch EE, Herbst AL et al. 2011 Adverse health outcomes in women exposed in utero to diethylstilbestrol. New England Journal of Medicine 365 1304-1314. (doi:10.1056/NEJMoa1013961)
91. Horne AW, King AE, Shaw E, McDonald SE, Williams AR, Saunders PT & Critchley HO 2009 Attenuated sex steroid receptor expression in fallopian tube of women with ectopic pregnancy. Journal of Clinical Endocrinology and Metabolism 94 5146-5154. (doi:10.1210/jc.2009-1476)
92. Horn-Ross PL, John EM, Canchola AJ, Stewart SL & Lee MM 2003 Phytoestrogen intake and endometrial cancer risk. Journal of the National Cancer Institute 95 1158-1164. (doi:10.1093/jnci/djg015)
93. Hwang LY, Ma Y, Benningfield SM, Clayton L, Hanson EN, Jay J, Jonte J, Godwin de Medina C & Moscicki AB 2009 Factors that influence the rate of epithelial maturation in the cervix in healthy young women. Journal of Adolescent Health 44 103-110. (doi:10.1016/j.jadohealth. 2008.10.006)
94. Jefferson WN, Padilla-Banks E, Clark G & Newbold RR 2002 Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. Journal of Chromato-graphy. B, Analytical Technologies in the Biomedical and Life Sciences 777 179-189. (doi:10.1016/S1570-0232(02)00493-2)
95. Johannisson E, Landgren BM, Rohr HP & Diczfalusy E 1987 Endometrial morphology and peripheral hormone levels in women with regular menstrual cycles. Fertility and Sterility 48 401-408.
96. Jordan VC 2003 Tamoxifen: a most unlikely pioneering medicine. Nature Reviews. Drug Discovery 2 205-213. (doi:10.1038/nrd1031)
97. Kabbarah O, Mallon MA, Pfeifer JD, Edelmann W, Kucherlapati R & Goodfellow PJ 2003 A panel of repeat markers for detection of microsatellite instability in murine tumors. Molecular Carcinogenesis 38 155-159. (doi:10.1002/mc.10157)
98. Kabbarah O, Mallon MA, Pfeifer JD & Goodfellow PJ 2006 Transcriptional profiling endometrial carcinomas microdissected from DES-treated mice identifies changes in gene expression associated with estrogenic tumor promotion. International Journal of Cancer 119 1843-1849. (doi:10.1002/ijc. 22063)
99. Kahn SE, Hull RL & Utzschneider KM 2006 Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444 840-846. (doi:10.1038/nature05482)
100. Kang K-S, Kim H-S, Ryu D-Y, Che J-H & Lee Y-S 2000 Immature uterotrophic assay is more sensitive than ovariectomized uterotrophic assay for the detection of estrogenicity of p-nonylphenol in Sprague-Dawley rats. Toxicology Letters 118 109-115. (doi:10.1016/S0378-4274(00)00272-1)
101. Kedar RP, Bourne TH, Powles TJ, Collins WP, Ashley SE, Cosgrove DO & Campbell S 1994 Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343 1318-1321. (doi:10.1016/S0140-6736(94)92466-X)
102. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA & Wilson EM 1995 Persistent DDT metabolite p, p-DDE is a potent androgen receptor antagonist. Nature 375 581-585. (doi:10.1038/375581a0)
103. Kerdivel G, Le Guevel R, Habauzit D, Brion F, Ait-Aissa S & Pakdel F 2013 Estrogenic potency of benzophenone UV filters in breast cancer cells: proliferative and transcriptional activity substantiated by docking analysis. PLoS ONE 8 e60567. (doi:10.1371/journal.pone.0060567)
104. Key TJ & Pike MC 1988 The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. British Journal of Cancer 57 205-212. (doi:10.1038/bjc.1988.44)
105. Kim HS, Shin JH, Moon HJ, Kang IH, Kim TS, Kim IY, Seok JH, Pyo MY & Han SY 2002 Comparative estrogenic effects of p-nonylphenol by 3-day uterotrophic assay and female pubertal onset assay. Reproductive Toxicology 16 259-268. (doi:10.1016/S0890-6238(02)00028-X)
106. Klinge CM, Kaur K & Swanson HI 2000 The aryl hydrocarbon receptor interacts with estrogen receptor a and orphan receptors COUP-TFI and ERRa1. Archives of Biochemistry and Biophysics 373 163-174. (doi:10.1006/abbi.1999. 1552)
107. Klotz DM, Beckman BS, Hill SM, McLachlan JA, Walters MR & Arnold SF 1996 Identification of environmental chemicals with estrogenic activity using a combination of in vitro assays. Environmental Health Perspectives 104 1084-1089. (doi:10.1289/ehp.961041084)
108. Klotz DM, Hewitt SC, Korach KS & Diaugustine RP 2000 Activation of a uterine insulin-like growth factor I signaling pathway by clinical and environmental estrogens: requirement of estrogen receptor-a. Endocrinology 141 3430-3439. (doi:10.1210/en.141.9.3430)
109. Knox SS, Jackson T, Javins B, Frisbee SJ, Shankar A & Ducatman AM 2011 Implications of early menopause in women exposed to perfluoro-carbons. Journal of Clinical Endocrinology and Metabolism 96 1747-1753. (doi:10.1210/jc.2010-2401)
110. Kogevinas M 2001 Human health effects of dioxins: cancer, reproductive and endocrine system effects. Human Reproduction Update 7 331-339. (doi:10.1093/humupd/7.3.331)
111. Kogevinas M, Becher H, Benn T, Bertazzi PA, Boffetta P, Bueno-de-Mesquita HB, Coggon D, Colin D, Flesch-Janys D, Fingerhut M et al. 1997 Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. American Journal of Epidemiology 145 1061-1075. (doi:10.1093/oxfordjournals.aje. a009069)
112. Krishnan AV, Stathis P, Permuth SF, Tokes L & Feldman D 1993 Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132 2279-2286. (doi:10.1210/en.132.6.2279)
113. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B & Gustafsson JA 1998 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor b. Endocrinology 139 4252-4263. (doi:10.1210/en.139.10.4252)
114. Kunz PY & Fent K 2006a Estrogenic activity of UV filter mixtures. Toxicology and Applied Pharmacology 217 86-99. (doi:10.1016/j.taap.2006.07.014)
115. Kunz PY & Fent K 2006b Multiple hormonal activities of UV filters and comparison of in vivo and in vitro estrogenic activity of ethyl-4-aminobenzoate in fish. Aquatic Toxicology 79 305-324. (doi:10.1016/j.aquatox.2006.06.016)
116. Kwekel JC, Forgacs AL, Burgoon LD, Williams KJ & Zacharewski TR 2009 Tamoxifen-elicited uterotrophy: cross-species and cross-ligand analysis of the gene expression program. BMC Medical Genomics 2 19. (doi:10.1186/1755-8794-2-19)
117. Lacey JV Jr, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A & Schairer C 2002 Menopausal hormone replacement therapy and risk of ovarian cancer. Journal of the American Medical Association 288 334-341. (doi:10.1001/jama.288.3.334)
118. La Vecchia C, Tavani A, Franceschi S & Parazzini F 1996 Oral contraceptives and cancer. A review of the evidence. Drug Safety 14 260-272. (doi:10.2165/00002018-199614040-00006)
119. Lee HJ, Chattopadhyay S, Gong EY, Ahn RS & Lee K 2003 Antiandrogenic effects of bisphenol A and nonylphenol on the function of androgen receptor. Toxicological Sciences 75 40-46. (doi:10.1093/toxsci/kfg150)
120. Li S, Washburn KA, Moore R, Uno T, Teng C, Newbold RR, McLachlan JA & Negishi M 1997 Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus. Cancer Research 57 4356-4359.
121. Li S, Hansman R, Newbold R, Davis B, McLachlan JA & Barrett JC 2003 Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus. Molecular Carcinogenesis 38 78-84. (doi:10.1002/mc.10147)
122. Li X, Ye L, Wang X, Liu H, Qian X, Zhu Y & Yu H 2012a Molecular docking, molecular dynamics simulation, and structure-based 3D-QSAR studies on estrogenic activity of hydroxylated polychlorinated biphenyls. Science of the Total Environment 441 230-238. (doi:10.1016/j.scitotenv. 2012.08.072)
123. Li Y, Burns KA, Arao Y, Luh CJ & Korach KS 2012b Differential estrogenic actions of endocrine-disrupting chemicals bisphenol A, bisphenol AF, and zearalenone through estrogen receptor a and b in vitro. Environmental Health Perspectives 120 1029-1035. (doi:10.1289/ehp.1104689)
124. Li Y, Luh CJ, Burns KA, Arao Y, Jiang Z, Teng CT, Tice RR & Korach KS 2013 Endocrine-disrupting chemicals (EDCs): in vitro mechanism of estro-genic activation and differential effects on ER target genes. Environmental Health Perspectives 121 459-466, 466e451-456. (doi:10.1289/ehp.1205951)
125. Lindemann K, Vatten LJ, Ellstrom-Engh M & Eskild A 2008 Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. British Journal of Cancer 98 1582-1585. (doi:10.1038/sj.bjc.6604313)
126. Liu JJ, Hazra A, Giovannucci E, Hankinson SE, Rosner B & De Vivo I 2013 One-carbon metabolism factors and endometrial cancer risk. British Journal of Cancer 108 183-187. (doi:10.1038/bjc.2012.534)
127. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS & Smithies O 1993 Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. PNAS 90 11162-11166. (doi:10.1073/pnas.90.23.11162)
128. Markey CM, Michaelson CL, Veson EC, Sonnenschein C & Soto AM 2001 The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. Environmental Health Perspectives 109 55-60. (doi:10.1289/ehp.0110955)
129. Marshall E, Lowrey J, MacPherson S, Maybin JA, Collins F, Critchley HO & Saunders PT 2011 In silico analysis identifies a novel role for androgens in the regulation of human endometrial apoptosis. Journal of Clinical Endocrinology and Metabolism 96 E1746-E1755. (doi:10.1210/jc.2011-0272)
130. Martucci C & Fishman J 1977 Direction of estradiol metabolism as a control of its hormonal action-uterotrophic activity of estradiol metabolites. Endocrinology 101 1709-1715. (doi:10.1210/endo-101-6-1709)
131. Masuyama H, Hiramatsu Y, Kodama J & Kudo T 2003 Expression and potential roles of pregnane X receptor in endometrial cancer. Journal of Clinical Endocrinology and Metabolism 88 4446-4454. (doi:10.1210/jc.2003-030203)
132. Masuyama H, Nakatsukasa H, Takamoto N & Hiramatsu Y 2007 Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells. Molecular Pharmacology 72 1045-1053. (doi:10.1124/mol.107.037937)
133. Matsushima A, Kakuta Y, Teramoto T, Koshiba T, Liu X, Okada H, Tokunaga T, Kawabata S, Kimura M & Shimohigashi Y 2007 Structural evidence for endocrine disruptor bisphenol A binding to human nuclear receptor ERRg. Journal of Biochemistry 142 517-524. (doi:10.1093/jb/mvm158)
134. Matthews J & Gustafsson JA 2003 Estrogen signaling: a subtle balance between ERa and ERb. Molecular Interventions 3 281-292. (doi:10.1124/mi.3.5.281)
135. Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL & Fishman J 1986 Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. New England Journal of Medicine 315 1305-1309. (doi:10.1056/NEJM198611203152101)
136. Miller KP, Borgeest C, Greenfeld C, Tomic D & Flaws JA 2004 In utero effects of chemicals on reproductive tissues in females. Toxicology and Applied Pharmacology 198 111-131. (doi:10.1016/j.taap.2003.07.016)
137. Mimura J & Fujii-Kuriyama Y 2003 Functional role of AhR in the expression of toxic effects by TCDD. Biochimica et Biophysica Acta 1619 263-268. (doi:10.1016/S0304-4165(02)00485-3)
138. Misso ML, Jang C, Adams J, Tran J, Murata Y, Bell R, Boon WC, Simpson ER & Davis SR 2005 Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. Menopause 12 210-215. (doi:10.1097/00042192-200512020-00016)
139. Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, Su JL, Kliewer SA, Lehmann JM & Willson TM 1998 Cloning and characterization of human estrogen receptor b isoforms. Biochemical and Biophysical Research Communications 247 75-78. (doi:10.1006/bbrc. 1998.8738)
140. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M & Masamune Y 2001 Interaction of phyto-estrogens with estrogen receptors a and b. Biological & Pharmaceutical Bulletin 24 351-356. (doi:10.1248/bpb.24.351)
141. Moriyama K, Tagami T, Akamizu T, Usui T, Saijo M, Kanamoto N, Hataya Y, Shimatsu A, Kuzuya H & Nakao K 2002 Thyroid hormone action is disrupted by bisphenol A as an antagonist. Journal of Clinical Endocrinology and Metabolism 87 5185-5190. (doi:10.1210/jc.2002-020209)
142. Munoz-de-Toro M, Beldomenico HR, Garcia SR, Stoker C, De Jesus JJ, Beldomenico PM, Ramos JG & Luque EH 2006 Organochlorine levels in adipose tissue of women from a littoral region of Argentina. Environmental Research 102 107-112. (doi:10.1016/j.envres.2005. 12.017)
143. Mutter GL, Lin MC, Fitzgerald JT, Kum JB, Baak JP, Lees JA, Weng LP & Eng C 2000 Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. Journal of the National Cancer Institute 92 924-930. (doi:10.1093/jnci/92.11.924)
144. Nagel SC, Hagelbarger JL & McDonnell DP 2001 Development of an ER action indicator mouse for the study of estrogens, selective ER modulators (SERMs), and xenobiotics. Endocrinology 142 4721-4728. (doi:10.1210/en.142.11. 4721)
145. Nair HB, Luthra R, Kirma N, Liu YG, Flowers L, Evans D & Tekmal RR 2005 Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation. Cancer Research 65 11164-11173. (doi:10.1158/0008-5472.CAN-05-1087)
146. Nantermet PV, Masarachia P, Gentile MA, Pennypacker B, Xu J, Holder D, Gerhold D, Towler D, Schmidt A, Kimmel DB et al. 2005 Androgenic induction of growth and differentiation in the rodent uterus involves the modulation of estrogen-regulated genetic pathways. Endocrinology 146 564-578. (doi:10.1210/en.2004-1132)
147. Newbold RR, Bullock BC & McLachlan JA 1990 Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Research 50 7677-7681.
148. Newbold RR, Hanson RB, Jefferson WN, Bullock BC, Haseman J & McLachlan JA 1998 Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethyl-stilbestrol. Carcinogenesis 19 1655-1663. (doi:10.1093/carcin/19.9. 1655)
149. Newbold RR, Padilla-Banks E, Snyder RJ & Jefferson WN 2005 Developmental exposure to estrogenic compounds and obesity. Birth Defects Research. Part A, Clinical and Molecular Teratology 73 478-480. (doi:10.1002/bdra.20147)
150. Newbold RR, Jefferson WN, Grissom SF, Padilla-Banks E, Snyder RJ & Lobenhofer EK 2007 Developmental exposure to diethylstilbestrol alters uterine gene expression that may be associated with uterine neoplasia later in life. Molecular Carcinogenesis 46 783-796. (doi:10.1002/mc.20308)
151. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M & Gustafsson JA 2001 Mechanisms of estrogen action. Physiological Reviews 81 1535-1565.
152. Ohta R, Takagi A, Ohmukai H, Marumo H, Ono A, Matsushima Y, Inoue T, Ono H & Kanno J 2012 Ovariectomized mouse uterotrophic assay of 36 chemicals. Journal of Toxicological Sciences 37 879-889. (doi:10.2131/jts.37.879)
153. Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, Tohyama C, Krust A, Mimura J, Chambon P et al. 2003 Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423 545-550. (doi:10.1038/nature01606)
154. Ouyang F, Perry MJ, Venners SA, Chen C, Wang B, Yang F, Fang Z, Zang T, Wang L, Xu X et al. 2005 Serum DDT, age at menarche, and abnormal menstrual cycle length. Occupational and Environmental Medicine 62 878-884. (doi:10.1136/oem.2005.020248)
155. Paige LA, Christensen DJ, Gron H, Norris JD, Gottlin EB, Padilla KM, Chang CY, Ballas LM, Hamilton PT, McDonnell DP et al. 1999 Estrogen receptor (ER) modulators each induce distinct conformational changes in ERa and ERb. PNAS 96 3999-4004. (doi:10.1073/pnas.96.7.3999)
156. Papaconstantinou AD, Umbreit TH, Fisher BR, Goering PL, Lappas NT & Brown KM 2000 Bisphenol A-induced increase in uterine weight and alterations in uterine morphology in ovariectomized B6C3F1 mice: role of the estrogen receptor. Toxicological Sciences 56 332-339. (doi:10.1093/toxsci/56.2.332)
157. Paruthiyil S, Cvoro A, Zhao X, Wu Z, Sui Y, Staub RE, Baggett S, Herber CB, Griffin C, Tagliaferri M et al. 2009 Drug and cell type-specific regulation of genes with different classes of estrogen receptor b-selective agonists. PLoS ONE 4 e6271. (doi:10.1371/journal.pone.0006271)
158. Pasqualini JR, Cornier E, Grenier J, Vella C, Schatz B & Netter A 1990 Effect of decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium. Fertility and Sterility 53 1012-1017.
159. Pellacani C, Buschini A, Galati S, Mussi F, Franzoni S & Costa LG 2012 Evaluation of DNA damage induced by 2 polybrominated diphenyl ether flame retardants (BDE-47 and BDE-209) in SK-N-MC cells. International Journal of Toxicology 31 372-379. (doi:10.1177/1091581812449663)
160. Peretz J, Gupta RK, Singh J, Hernandez-Ochoa I & Flaws JA 2011 Bisphenol A impairs follicle growth, inhibits steroidogenesis, and downregulates rate-limiting enzymes in the estradiol biosynthesis pathway. Toxicological Sciences 119 209-217. (doi:10.1093/toxsci/kfq319)
161. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson JA & Carlquist M 1999 Structure of the ligand-binding domain of oestrogen receptor b in the presence of a partial agonist and a full antagonist. EMBO Journal 18 4608-4618. (doi:10.1093/emboj/18. 17.4608)
162. Ponzo OJ & Silvia C 2013 Evidence of reproductive disruption associated with neuroendocrine changes induced by UV-B filters, phtalates and nonylphenol during sexual maturation in rats of both gender. Toxicology 311 41-51. (doi:10.1016/j.tox.2013.05.014)
163. Punyadeera C, Dunselman G, Marbaix E, Kamps R, Galant C, Nap A, Goeij A, Ederveen A & Groothuis P 2004 Triphasic pattern in the ex vivo response of human proliferative phase endometrium to oestrogens. Journal of Steroid Biochemistry and Molecular Biology 92 175-185. (doi:10.1016/j.jsbmb.2004.06.005)
164. Purdie DM & Green AC 2001 Epidemiology of endometrial cancer. Best Practice & Research. Clinical Obstetrics & Gynaecology 15 341-354. (doi:10.1053/beog.2000.0180)
165. Rinaldi S, Plummer M, Biessy C, Castellsague X, Overvad K, Kruger Kjaer S, Tjonneland A, Clavel-Chapelon F, Chabbert-Buffet N, Mesrine S et al. 2011 Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study. Cancer Epidemiology, Biomarkers & Prevention 20 2532-2540. (doi:10.1158/1055-9965.EPI-11-0753)
166. Rodriguez Y, Baez D, de Oca FM, Garcia C, Dorta I, Reyes R, Valladares F, Almeida TA & Bello AR 2011 Comparative analysis of the ERa/ERb ratio and neurotensin and its high-affinity receptor in myometrium, uterine leiomyoma, atypical leiomyoma, and leiomyosarcoma. International Journal of Gynecological Pathology 30 354-363. (doi:10.1097/PGP. 0b013e31820918cb)
167. Sakaguchi H, Fujimoto J, Aoki I & Tamaya T 2003 Expression of estrogen receptor a and b in myometrium of premenopausal and postmenopausal women. Steroids 68 11-19. (doi:10.1016/S0039-128X(02)00111-3)
168. Schlecht C, Klammer H, Wuttke W & Jarry H 2006 A dose-response study on the estrogenic activity of benzophenone-2 on various endpoints in the serum, pituitary and uterus of female rats. Archives of Toxicology 80 656-661. (doi:10.1007/s00204-006-0085-1)
169. Schoeters G, Den Hond E, Dhooge W, van Larebeke N & Leijs M 2008 Endocrine disruptors and abnormalities of pubertal development. Basic Clinical Pharmacology & Toxicology 102 168-175. (doi:10.1111/j.1742-7843.2007.00180. x)
170. Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen N, Weiss NS, Webb PM et al. 2013 Type I and II endometrial cancers: have they different risk factors? Journal of Clinical Oncology 31 2607-2618. (doi:10.1200/JCO.2012.48.2596)
171. Shelby MD, Newbold RR, Tully DB, Chae K & Davis VL 1996 Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environmental Health Perspectives 104 1296-1300. (doi:10.1289/ehp.961041296)
172. Sierens JE, Scobie GA, Wilson J & Saunders PT 2004 Cloning of oestrogen receptor b from Old and New World primates: identification of splice variants and functional analysis. Journal of Molecular Endocrinology 32 703-718. (doi:10.1677/jme.0.0320703)
173. Simpson ER 2003 Sources of estrogen and their importance. Journal of Steroid Biochemistry and Molecular Biology 86 225-230. (doi:10.1016/S0960- 0760(03)00360-1)
174. Smith CC & Taylor HS 2007 Xenoestrogen exposure imprints expression of genes (Hoxa10) required for normal uterine development. FASEB Journal 21 239-246. (doi:10.1096/fj.06-6635com)
175. Sturgeon SR, Brock JW, Potischman N, Needham LL, Rothman N, Brinton LA & Hoover RN 1998 Serum concentrations of organochlorine compounds and endometrial cancer risk (United States). Cancer Causes & Control 9 417-424. (doi:10.1023/A:1008823802393)
176. Stygar D, Wang H, Vladic YS, Ekman G, Eriksson H & Sahlin L 2001 Co-localization of oestrogen receptor b and leukocyte markers in the human cervix. Molecular Human Reproduction 7 881-886. (doi:10.1093/molehr/7.9.881)
177. Sui Y, Ai N, Park SH, Rios-Pilier J, Perkins JT, Welsh WJ & Zhou C 2012 Bisphenol A and its analogues activate human pregnane X receptor. Environmental Health Perspectives 120 399-405. (doi:10.1289/ehp. 1104426)
178. Sun J, Meyers MJ, Fink BE, Rajendran R, Katzenellenbogen JA & Katzenellenbogen BS 1999 Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-A or estrogen receptor-b. Endocrinology 140 800-804. (doi:10.1210/en.140.2.800)
179. Takayanagi S, Tokunaga T, Liu X, Okada H, Matsushima A & Shimohigashi Y 2006 Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor g (ERRg) with high constitutive activity. Toxicology Letters 167 95-105. (doi:10.1016/j.toxlet.2006.08.012)
180. Tamae D, Byrns M, Marck B, Mostaghel EA, Nelson PS, Lange P, Lin D, Taplin ME, Balk S, Ellis W et al. 2013 Development, validation and application of a stable isotope dilution liquid chromatography electrospray ionization/selected reaction monitoring/mass spectrometry (SID-LC/ESI/SRM/MS) method for quantification of keto-androgens in human serum. Journal of Steroid Biochemistry and Molecular Biology 138C 281-289. (doi:10.1016/j.jsbmb.2013.06. 014)
181. Tantamango-Bartley Y, Jaceldo-Siegl K, Fan J & Fraser G 2013 Vegetarian diets and the incidence of cancer in a low-risk population. Cancer Epidemiology, Biomarkers & Prevention 22 286-294. (doi:10.1158/1055-9965. EPI-12-1060)
182. Taylor AH & Al-Azzawi F 2000 Immunolocalisation of oestrogen receptor b in human tissues. Journal of Molecular Endocrinology 24 145-155. (doi:10.1677/jme.0.0240145)
183. Taylor HS, Vanden Heuvel GB & Igarashi P 1997 A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes. Biology of Reproduction 57 1338-1345. (doi:10.1095/biolreprod57.6.1338)
184. Teng C, Goodwin B, Shockley K, Xia M, Huang R, Norris J, Merrick BA, Jetten AM, Austin CP & Tice RR 2013 Bisphenol A affects androgen receptor function via multiple mechanisms. Chemico-Biological Interactions 203 556-564. (doi:10.1016/j.cbi.2013.03.013)
185. Thomas CC, Wingo PA, Dolan MS, Lee NC & Richardson LC 2009 Endometrial cancer risk among younger, overweight women. Obstetrics and Gynecology 114 22-27. (doi:10.1097/AOG.0b013e3181ab6784)
186. Tinwell H & Ashby J 2004 Sensitivity of the immature rat uterotrophic assay to mixtures of estrogens. Environmental Health Perspectives 112 575-582. (doi:10.1289/ehp.6831)
187. Tinwell H, Joiner R, Pate I, Soames A, Foster J & Ashby J 2000 Uterotrophic activity of bisphenol A in the immature mouse. Regulatory Toxicology and Pharmacology 32 118-126. (doi:10.1006/rtph.2000.1412)
188. Troisi R, Hatch EE, Titus-Ernstoff L, Hyer M, Palmer JR, Robboy SJ, Strohsnitter WC, Kaufman R, Herbst AL & Hoover RN 2007 Cancer risk in women prenatally exposed to diethylstilbestrol. International Journal of Cancer 121 356-360. (doi:10.1002/ijc.22631)
189. Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S & Di Renzo GC 2004 Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertility and Sterility 82 145-148 quiz 265. (doi:10.1016/j.fertnstert.2003.11.041)
190. Varayoud J, Ramos JG, Bosquiazzo VL, Lower M, Munoz-de-Toro M & Luque EH 2011 Neonatal exposure to bisphenol A alters rat uterine implantation-associated gene expression and reduces the number of implantation sites. Endocrinology 152 1101-1111. (doi:10.1210/en.2009-1037)
191. Vasiliu O, Muttineni J & Karmaus W 2004 In utero exposure to organochlorines and age at menarche. Human Reproduction 19 1506-1512. (doi:10.1093/humrep/deh292)
192. Vuorinen A, Odermatt A & Schuster D 2013 In silico methods in the discovery of endocrine disrupting chemicals. Journal of Steroid Biochemistry and Molecular Biology 137 18-26. (doi:10.1016/j.jsbmb.2013.04.009)
193. Walker DM, Kermath BA, Woller MJ & Gore AC 2013 Disruption of reproductive aging in female and male rats by gestational exposure to estrogenic endocrine disruptors. Endocrinology 154 2129-2143. (doi:10.1210/en.2012-2123)
194. Wallace AE, Gibson DA, Saunders PT & Jabbour HN 2010 Inflammatory events in endometrial adenocarcinoma. Journal of Endocrinology 206 141-157. (doi:10.1677/JOE-10-0072)
195. Warner M, Samuels S, Mocarelli P, Gerthoux PM, Needham L, Patterson DG Jr & Eskenazi B 2004 Serum dioxin concentrations and age at menarche. Environmental Health Perspectives 112 1289-1292. (doi:10.1289/ehp.7004)
196. Watanabe H, Suzuki A, Goto M, Lubahn DB, Handa H & Iguchi T 2004 Tissue-specific estrogenic and non-estrogenic effects of a xenoestrogen, nonylphenol. Journal of Molecular Endocrinology 33 243-252. (doi:10.1677/jme.0. 0330243)
197. Weiderpass E & Baron JA 2001 Cigarette smoking, alcohol consumption, and endometrial cancer risk: a population-based study in Sweden. Cancer Causes & Control 12 239-247. (doi:10.1023/A:1011201911664)
198. Weiderpass E, Adami HO, Baron JA, Wicklund-Glynn A, Aune M, Atuma S & Persson I 2000 Organochlorines and endometrial cancer risk. Cancer Epidemiology, Biomarkers & Prevention 9 487-493.
199. Wormke M, Castro-Rivera E, Chen I & Safe S 2000 Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells. Journal of Steroid Biochemistry and Molecular Biology 72 197-207. (doi:10.1016/S0960-0760(00)00030-3)
200. Wu JJ, Geimonen E & Andersen J 2000 Increased expression of estrogen receptor b in human uterine smooth muscle at term. European Journal of Endocrinology/European Federation of Endocrine Societies 142 92-99. (doi:10.1530/eje.0.1420092)
201. Yamasaki K, Sawaki M & Takatsuki M 2000 Immature rat uterotrophic assay of bisphenol A. Environmental Health Perspectives 108 1147-1150. (doi:10.1289/ehp.001081147)
202. Zang H, Sahlin L, Masironi B, Eriksson E & Linden Hirschberg A 2007 Effects of testosterone treatment on endometrial proliferation in postmeno-pausal women. Journal of Clinical Endocrinology and Metabolism 92 2169-2175. (doi:10.1210/jc.2006-2171)